Elsevier

Nutrition

Volume 71, March 2020, 110620
Nutrition

Applied nutritional investigation
Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features

https://doi.org/10.1016/j.nut.2019.110620Get rights and content

Highlights

  • Sedentary lifestyle and lower adherence to the Mediterranean diet is associated with risk for non-alcoholic fatty liver disease in older individuals diagnosed with metabolic syndrome.

  • Higher legume intake is related to an improvement in liver status.

  • Recommendations of healthy lifestyles for the prevention and management of non-alcoholic fatty liver disease in patients at high cardiovascular risk are warranted.

Abstract

Objective

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver morbidity. This condition often is accompanied by obesity, diabetes, and metabolic syndrome (MetS). The aim of this study was to evaluate the connection between lifestyle factors and NAFLD in individuals with MetS.

Methods

A cross-sectional study with 328 participants (55–75 y of age) diagnosed with MetS participating in the PREDIMED-Plus trial was conducted. NAFLD status was evaluated using the non-invasive hepatic steatosis index (HSI). Sociodemographic, clinical, and dietary data were collected. Adherence to the Mediterranean diet (mainly assessed by the consumption of olive oil, nuts, legumes, whole grain foods, fish, vegetables, fruits, and red wine) and physical activity were assessed using validated questionnaires.

Results

Linear regression analyses revealed that HSI values tended to be lower with increasing physical activity tertiles (T2, β = –1.47; 95% confidence interval [CI], –2.73 to –0.20; T3, β = –1.93; 95% CI, –3.22 to –0.65 versus T1, Ptrend = 0.001) and adherence to the Mediterranean diet was inversely associated with HSI values: (moderate adherence β = –0.70; 95% CI, –1.92 to 0.53; high adherence β = –1.57; 95% CI, –3.01 to –0.13 versus lower, Ptrend = 0.041). Higher tertiles of legume consumption were inversely associated with the highest tertile of HSI (T2, relative risk ratio [RRR], 0.45; 95% CI, 0.22–0.92; P = 0.028; T3, RRR, 0.48; 95% CI, 0.24–0.97; P = 0.041 versus T1).

Conclusion

Physical activity, adherence to the Mediterranean diet, and consumption of legumes were inversely associated with a non-invasive marker of NAFLD in individuals with MetS. This data can be useful in implementing precision strategies aimed at the prevention, monitoring, and management of NAFLD.

Introduction

Non-alcoholic fatty liver disease (NAFLD) has become a prevalent chronic liver disease, as it is the primary cause of liver-related morbidity and mortality [1]. The increasing rates of NAFLD most likely accompany the increase in incidence of obesity, type 2 diabetes, metabolic syndrome (MetS), and cardiovascular disease (CVD) [2,3], especially in Western countries [1]. Indeed, NAFLD is a multifactorial chronic condition whose pathogenesis results from a complex interaction among genes, gut microbiota, and lifestyle factors [4]. Furthermore, the aging process is associated with an increased risk for developing cardiometabolic abnormalities and NAFLD progression [5]. NAFLD encompasses a spectrum of liver damage features being characterized at the initial stage by an excessive accumulation of intrahepatic triacylglycerols, which can progress to non-alcoholic steatohepatitis (NASH) and eventually lead to cirrhosis, hepatocellular carcinoma (HCC), or both if not detected early and treated [4]. Liver biopsy is the gold standard for NAFLD diagnoses [4]. However, it is an expensive and invasive procedure that may result in clinical complications [4]. Thus, several alternative non-invasive liver scores have been devised and developed [2], [3], [4]. The hepatic steatosis index (HSI) has demonstrated good performance in several population studies and has been used for large-scale NAFLD primary screening [6], [7], [8]. The management of all stages of NAFLD has been focused on improving the metabolic profile by encouraging a healthy lifestyle, such as adherence to certain dietary patterns and increased physical activity [2], [3], [4]. The Mediterranean diet (MedDiet) is a healthy dietary pattern that includes high consumption of plant-derived foods (fruits, vegetables, and legumes), whole grain foods, fish, olive oil, nuts, and low to moderate intake of red wine, meat, and dairy products [9]. Additionally, the MedDiet has demonstrated beneficial effects on the lipid profile, glycemic control, and blood pressure [10]. The presence of these clinical conditions are associated with higher risk for NAFLD and more advanced disease stages [2]. Epidemiologic and clinical studies have suggested that staple components of the MedDiet provide specific health bioactive compounds with healthy antioxidant and anti-inflammatory properties [10], [11], [12], [13]. In fact, the effects of the MedDiet on liver status could be attributed to specific compounds such as polyphenols, fiber, carotenoids, ω-3 polyunsaturated fatty acid (PUFA), and oleic acid [12,14] Physical activity has been shown to potentially reduce hepatic steatosis and improve insulin resistance, some MetS features, and cardiovascular events [15]. Current available recommendations suggest weight loss for NAFLD treatment (–5% or –10% of initial body weight) as the key intervention based on energy restriction. However, not only is the loss of body weight important but the characteristics of nutrient composition as well as adherence to a healthy lifestyle should be strongly considered in treatment of this disease [4]. To our knowledge, there is little available data regarding lifestyle factors of older patients with MetS. Against this background, we hypothesized that lifestyle factors, especially adherence to the MedDiet and nutritional/food characteristics and physical activity, would be associated with a decreased risk for NAFLD in a population of aduklts 55 to 75 y of age diagnosed with MetS at high cardiovascular risk.

Section snippets

Study population and design

The PREDIMED-Plus study is a multicenter randomized trial designed to investigate the effect on CVD morbidity and mortality reduction. A detailed protocol of the study methods and population characteristics has been published previously [16]. In brief, the study recruited 6874 individuals from 23 centers located in Spain. Participants enrolled had to meet the following inclusion criteria: men ages 55 to 75 y and women ages 60 to 75 y with a body mass index (BMI) ≥27 and <40 kg/m2 fulfilling at

Participants’ characteristics

No significant differences were observed in the mean age among groups (Table 1). Participants included in the 3rd tertile of the HSI registered higher BMI and waist circumference than the rest of participants. Also, a worse glucose metabolism control was observed in these group of participants (3rd tertile) with significantly higher glucose, TyG index, a higher frequency of diabetics (all p <0.001), and HbA1c (p = 0.001). No significant differences were observed in blood pressure (systolic and

Discussion

Emerging clinical data have established a close relationship between NAFLD and MetS [31]. In this cross-sectional cohort study, key components related to cardiometabolic risk factors disclosed a direct association with higher HSI values. To the best of our knowledge, this was the first study to evaluate the relationship between lifestyle factors and the specific role of typical Mediterranean foods, with NAFLD characteristics in an older population diagnosed with MetS. In particular, the HSI has

Conclusions

This study suggested that lifestyle modifications focused on physical activity and fostering adherence to the MedDiet in older adults diagnosed with MetS might exert beneficial effects on liver status. Moreover, some foods such as legumes may play a beneficial role in the improvement of hepatic steatosis reducing the risk for NAFLD. The present findings support the recommendation of lifestyle changes (nutrition and physical activity) as a cornerstone for the prevention and precise management of

Conflicts of Interest

None of the authors reported a conflict of interest.

References (52)

  • M.V. Bullón-Vela et al.

    Obesity and nonalcoholic fatty liver disease: role of oxidative stress

  • I. Cantero et al.

    Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial

    Clin Nutr

    (2018)
  • I.-P. Kalafati et al.

    Dietary patterns and non-alcoholic fatty liver disease in a Greek case–control study

    Nutrition

    (2019)
  • T. Bacchetti et al.

    Relationship of fruit and vegetable intake to dietary antioxidant capacity and markers of oxidative stress: a sex-related study

    Nutrition

    (2019)
  • S. Zelber-Sagi et al.

    High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance

    J Hepatol

    (2018)
  • R. Kongkachuichai et al.

    Heme and nonheme iron content of animal products commonly consumed in Thailand

    J Food Compos Anal

    (2002)
  • Z. Younossi et al.

    Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

    Nat Rev Gastroenterol Hepatol

    (2018)
  • M.E. Rinella

    Nonalcoholic fatty liver disease

    JAMA

    (2015)
  • N. Chalasani et al.

    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

    Hepatology

    (2018)
  • L. Gan et al.

    Mechanisms and implications of age-related changes in the liver: nonalcoholic fatty liver disease in the elderly

    Curr Gerontol Geriatr Res

    (2011)
  • L. Fedchuk et al.

    Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

    Aliment Pharmacol Ther

    (2014)
  • R. Estruch

    Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study

    Proc Nutr Soc

    (2010)
  • J. Godos et al.

    Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection

    Int J Food Sci Nutr

    (2017)
  • T. Eslamparast et al.

    Dietary composition independent of weight loss in the management of non-alcoholic fatty liver disease

    Nutrients

    (2017)
  • S. Zelber-Sagi et al.

    The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms

    Liver Int

    (2017)
  • M. Whitsett et al.

    Physical activity as a treatment of non-alcoholic fatty liver disease: a systematic review

    World J Hepatol

    (2015)
  • Cited by (0)

    This work was supported by the Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS, PI14/01919 and PI17/00926), co-funded by the European Regional Development Fund (ERDF), CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and by European Research Council (Advanced Research Grant 2014-2019; agreement #340918 granted to MAM-G). VBV received a grant from the Center for Nutrition Research of the University of Navarra. VBV and IA contributed equally to this study. VBV, IA, MAZ, and JAM were involved in conceptualization, design, acquisition of data, analysis, and interpretation of data; writing of the original draft preparation; and critical revision of the manuscript for important intellectual content. JAT, XP, EC, MAM-G, ET, DC, MM, FT, MF, RE, ER, JS-S, and LD were involved in study design, acquisition of data, and interpretation data; and critical revision of the manuscript for important intellectual content. All authors approved the final version of the manuscript. The authors have no conflicts of interest to declare.

    View full text